GleamWall
中文EN

PHVS Pharvaris N.V. IFRS

Pharmaceutical Preparations · Nasdaq · SEC CIK 1830487 · Reporting currency EUR · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY-30.9%
TTM EPS YoY-19.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-65.2%
ROA-59.3%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets10.0%
Debt / equity0.00x
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.78x
Accruals ratio-13.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: EUR 2025Q2*2025-06-302024Q2*2024-06-302023Q22023-06-302022Q22022-06-302021Q22021-06-30
Income statement
Revenue—————
R&D expense29.61M23.07M14.68M13.72M8.06M
SG&A expense10.77M11.31M7.77M7.66M4.66M
Operating income-45.28M-29.66M-21.80M-9.88M-15.20M
Income tax202,78270,62394,1782.74M2,965
Net income-45.48M-29.73M-21.90M-12.71M-15.20M
EPS (basic)-0.83-0.55-0.63-0.38-0.46
EPS (diluted)-0.83-0.55-0.63-0.38-0.46
Weighted avg. shares (diluted)54.69M53.94M34.56M33.58M33.13M
Balance sheet
Cash & equivalents199.57M343.57M179.19M201.38M224.32M
Receivables2.60M1.61M334,299331,928—
PP&E, netmay include right-of-use assets (IFRS)719,994258,551220,138141,846—
Total assets209.81M351.85M189.74M206.74M—
Total liabilities25.47M19.08M16.01M16.17M—
Shareholders' equity184.34M332.77M173.73M190.57M222.23M
Cash flow statement
Operating cash flow—————

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.